Consultation outcome

Reclassification of Otrivine extra dual relief nasal spray solution (ARM 90)

This consultation has concluded

Original consultation

Summary

MHRA is asking for feedback on proposals to change the legal classification of Otrivine extra dual relief nasal spray solution from prescription only medicine (POM) to pharmacy only (P).

This consultation ran from
to